Fiduciary Group LLC Sells 277 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fiduciary Group LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,767 shares of the medical equipment provider’s stock after selling 277 shares during the period. Intuitive Surgical comprises 1.2% of Fiduciary Group LLC’s investment portfolio, making the stock its 19th largest position. Fiduciary Group LLC’s holdings in Intuitive Surgical were worth $11,883,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $558,807,000. Proficio Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC raised its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 1.7 %

NASDAQ ISRG opened at $492.06 on Thursday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market capitalization of $175.26 billion, a PE ratio of 76.76, a P/E/G ratio of 5.85 and a beta of 1.43. The stock’s 50 day moving average is $564.39 and its 200 day moving average is $531.62.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ISRG shares. Robert W. Baird decreased their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.